arrow
C

Craig Nolan

Memorial Sloan Kettering Cancer Center
H指数:23
被引数:3,017

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prospective characterization of germline variants in patients with gliomas and glioneuronal tumors

胶质瘤和神经胶质神经元肿瘤患者胚系变异的前瞻性表征

2025-09-120
OAAI
Phase Ib study with expansion of ibrutinib, lenalidomide, and rituximab in patients with relapsed/refractory central nervous system lymphoma

Ib期研究:在复发/难治性中枢神经系统淋巴瘤患者中扩大伊布替尼、来那度胺和利妥昔单抗的应用

2025-06-010
PRE
PROSPECTIVE GERMLINE SEQUENCING OF PATIENTS WITH GLIOMAS, GLIONEURONAL OR NEURONAL TUMORS
2024-11-110
PRE
Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma
2017-08-31293
OAAI
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma

将2-羟基戊二酸-质子磁共振波谱整合到异柠檬酸脱氢酶突变型神经胶质瘤疾病监测的临床实践中

2015-12-20142
OAAI
Phase II Study of Bevacizumab, Temozolomide, and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma
2014-09-3084
OAAI
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma

持续低剂量替莫唑胺治疗复发性恶性胶质瘤的II期试验

2012-12-1482
OAAI